Arkolith/Insider Trading/GYRE/Form 4

Ma Songjiang

President, DirectorGYRE THERAPEUTICS, INC. (GYRE) · full profile →Form 4 · filed Feb 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$50K
Net Open-Market Flow
-$50K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 7, 2025Sell(S)2K$12.16$24K2.9M
Feb 6, 2025Sell(S)2K$12.85$26K2.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-003831) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML